HERMIONE: A randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

  1. Miller, K.
  2. Cortes, J.
  3. Hurvitz, S.A.
  4. Krop, I.E.
  5. Tripathy, D.
  6. Verma, S.
  7. Riahi, K.
  8. Reynolds, J.G.
  9. Wickham, T.J.
  10. Molnar, I.
  11. Yardley, D.A.
Zeitschrift:
BMC Cancer

ISSN: 1471-2407

Datum der Publikation: 2016

Ausgabe: 16

Nummer: 1

Art: Artikel

DOI: 10.1186/S12885-016-2385-Z GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus